Vitiligo pp 25-32 | Cite as


  • Flávia Pretti AslanianEmail author
  • Absalom Filgueira
  • Tullia Cuzzi
  • Béatrice Vergier

Core Messages

  • › Adjacent, apparently normally pigmented skin should always be included to compare pig-mented and non-pigmented skin.

  • › It is important to indicate to the pathologist whether the lesion is stable or progressive.

  • › The main histological finding in vitiligo is a marked reduction or absence of pigmentation along the basal layer of the epidermis.

  • › Absence or loss of melanocytes in vitiligo leads to an absence of melanin resulting in depigmen-tation. Histochemistry (Fontana-Masson stain) and immunohistochemistry help to demonstrate pigment and cell loss.

  • › Associated inflammatory changes and/or pigmentary incontinence may or may not be present, in variable intensity, generally mild, and are noted at an early stage at the border of progressing lesions.

  • › Histopathology is needed to rule out other causes of acquired hypopigmentation, especially mycosis fungoides and leprosy.


Basal Layer Mycosis Fungoides Outer Root Sheath Vitiligo Patient Active Vitiligo 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ackerman AB, Chongchinant N, Sanchez J et al (1997) Histologic diagnosis of inflammatory skin diseases. An algorithmic method based on pattern analysis, 2nd edn. Williams &Wilkins, Baltimore, MDGoogle Scholar
  2. 2.
    Ackerman AB, Kerl H, Sánchez J (2000) A clinical atlas of 101 common skin diseases (with histopathologic correlation), 1st edn. Ardor Scribendi, New York, pp 645–650Google Scholar
  3. 3.
    Ahn SK, Choi EH, Lee SH et al (1994) Immunohistochemical studies from vitiligo—comparison between active and inactive lesions. Yonsei Med J 35:404–410PubMedGoogle Scholar
  4. 4.
    Al Badri AMT, Todd PM, Garioch JJ et al (1993). An immuno-logical study of cutaneous lymphocytes in vitiligo. J Pathol 170:149–155CrossRefGoogle Scholar
  5. 5.
    Attili VR, Attili SK (2008) Lichenoid inflammation in vitiligo—a clinical and histopathologic review of 210 cases. Int J Dermatol 47:663–669PubMedCrossRefGoogle Scholar
  6. 6.
    Bhawan J, Bhutani LK (1983) Keratinocyte damage in viti-ligo. J Cutan Pathol 10:207–212PubMedCrossRefGoogle Scholar
  7. 7.
    Clarkson KS, Sturdgess IC, Molyneux AJ (2001) The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103(anti-melan-A). J Clin Pathol 54:196–200PubMedCrossRefGoogle Scholar
  8. 8.
    Dean NR, Brennan J, Haynes J et al (2002) Immuno-histochemical labelling of normal melanocytes. Appl Immu-nohistochem Mol Morphol 10:199–204CrossRefGoogle Scholar
  9. 9.
    El-Darouti MA, Marzouk SA, Azzam O et al (2006) Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis). Eur J Dermatol 16:17–22PubMedGoogle Scholar
  10. 10.
    Gokhale BB, Mehta LN (1983) Histopathology of vitiligi-nous skin. Int J Dermatol 22:477–480PubMedCrossRefGoogle Scholar
  11. 11.
    Hann SK, Kim YS, Yoo JH (2000) Clinical and histopatho-logic characteristics of trichrome vitiligo. J Am Acad Dermatol 242:589–596Google Scholar
  12. 12.
    Hann SK, Park YK, Lee KG et al (1992) Epidermal changes in active vitiligo. J Dermatol 19:217–222PubMedGoogle Scholar
  13. 13.
    Horn TD, Abanmi A (1997) Analysis of the lymphocytic infil-trate in a case of vitiligo. Am J Dermatopathol 19:400–402PubMedCrossRefGoogle Scholar
  14. 14.
    Kao CH, Yu HS (1990) Depletion and repopulation of Langerhans cells in nonsegmental type vitiligo. J Dermatol 17:287–96PubMedGoogle Scholar
  15. 15.
    Kim YC, Kim YJ, Kang HY et al (2008) Histopathologic features in vitiligo. Am J Dermatopathol 30:112–116PubMedCrossRefGoogle Scholar
  16. 16.
    Koranne RV, Sachdeva KG (1988) Vitiligo. Int J Dermatol 27:676–681PubMedCrossRefGoogle Scholar
  17. 17.
    Kovacs SO (1998) Vitiligo. J Am Acad Dermatol 38:647–666PubMedCrossRefGoogle Scholar
  18. 18.
    Lee HS, Chun YS, Hann SK (1999) Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients. J Am Acad Dermatol 40:21–26PubMedCrossRefGoogle Scholar
  19. 19.
    Le Poole IC, Van den Wijngaard RM, Westerhof W et al (1996) Presence of T-cells and macrophages in inflamma-tory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148:1219–1228PubMedGoogle Scholar
  20. 20.
    Le Poole IC, Van den Wijngaard RM, Westerhof W et al (1993) Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 100:816–822PubMedCrossRefGoogle Scholar
  21. 21.
    Moellmann G, Klein-Angerer S, Scollay DA et al (1982) Extracellular granular material and degeneration of kerati-nocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 79:321–330PubMedCrossRefGoogle Scholar
  22. 22.
    Montes LF, Abulafia J, Wilborn WH et al (2003) Value of histopathology in vitiligo. Int J Dermatol 42:57–61PubMedCrossRefGoogle Scholar
  23. 23.
    Mosher DB, Fitzpatrick TB, Ortonne JB et al (1999) Hypomelanoses and hypermelanoses. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB et al (eds) Dermatology in general medicine, 5th edn. McGraw-Hill, New York, pp 945–1017Google Scholar
  24. 24.
    Mosher DB, Fitzpatrick TB, Ortonne JB et al (1999) Normal skin color and general considerations of pigmentary disorders. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB et al (eds) Dermatology in general medicine, 5th edn. McGraw-Hill, New York, pp 936–944Google Scholar
  25. 25.
    Murphy FG (2005) Histology of the skin. In: Elder D, Elenitsas R, Jaworsky C, Johnson B (eds) Lever's histopathology of the skin, 9th edn. Lipincott Williams&Wilkins, Philadelphia, pp 16–17Google Scholar
  26. 26.
    Pretti Aslanian FM, Noe RA, Cuzzi T et al (2007) Abnormal histological findings in active vitiligo include the normal-appearing skin. Pigment Cell Res 20:144–145PubMedCrossRefGoogle Scholar
  27. 27.
    Sharquie KE, Mehenna SH, Naji AA et al (2004) Inflammatory changes in vitiligo. Stage I and II depigmenta-tion. Am J Dermatopathol 26:108–112CrossRefGoogle Scholar
  28. 28.
    Spielvogel RL, Kantor GR (1997) Pigmentary disorders of the skin. In: Elder D, Elenitsas R, Jaworsky C et al (eds) Lever's histopathology of the skin, 8th edn. Lipincott-Raven, Philadelphia, pp 617–623Google Scholar
  29. 29.
    Tretiakova MS, Shea CR, Petronic-Rosic VM (2006) Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol 19:1255–1260PubMedCrossRefGoogle Scholar
  30. 30.
    Van den Wijngaard R, Wañkowicz-Kaliñska A, Le Poole C et al (2000) Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the proeminent presence of CLA+T-cells at the perile-sional site. Lab Invest 80:1299–309PubMedCrossRefGoogle Scholar
  31. 31.
    Wankowicz-Kalinska A, Van den Wijngaard RM, Tigges BJ et al (2003) Immunopolarization of CD4+ and CD8+ T-cells to type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 83:683–695PubMedGoogle Scholar
  32. 32.
    Weedon D, Strutton G (2002) Disorders of pigmentation. Skin pathology, 2nd edn. Churchill Livingston, London, pp 321–341Google Scholar
  33. 33.
    Westerhof W, Groot I, Krieg SR et al (1986) Langerhans'cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and U VA irradiation. Acta Derm Venereol 66:259–262PubMedGoogle Scholar
  34. 34.
    Wick MR (2006) Immunohistology of melanocytic neoplasms. In: Dabbs DJ (ed). Diagnostic immunohistochemis-try, 2nd edn. Churchill Livingstone, Pittsburgh, PA, pp 166–168Google Scholar
  35. 35.
    Wolff RK, Johnson RA, Surmond D (2005) Pigmentary disorders. In: Fitzpatrick's color atlas &synopsis of clinical dermatology, 5th edn. McGraw-Hill, New York, pp 336–343Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Flávia Pretti Aslanian
    • 1
    Email author
  • Absalom Filgueira
    • 2
  • Tullia Cuzzi
    • 3
  • Béatrice Vergier
    • 4
  1. 1.Federal University of Rio de JaneiroRio de JaneiroBrasil
  2. 2.Department of DermatologyFederal University of Rio de JaneiroLeblonBrasil
  3. 3.Federal University of Rio de JaneiroRio de JaneiroBrasil
  4. 4.Department of PathologyHôpital du Haut Lév®queBordeauxFrance

Personalised recommendations